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Introduction: Natural killer (NK) cells play a critical role in the innate immune
response to viruses and tumors, and comprise a large proportion of the hepatic
lymphocyte population. They must remain tolerant to non-pathogenic antigens
while protecting the host from harmful agents. Herein, we investigate how the NK
cell response to activation receptor engagement is altered in the liver.
Methods: In this study, we assess IFN-g production and degranulation of splenic
NK cells and selected subsets of liver NK cells. Flow cytometry (FCM) was used to
asses IFN-g production and degranulation following stimulation of the NK cells
with plate bound antibodies to activating receptors.
Results: We show that smaller percentages of hepatic NK cells produce interferon
(IFN)–g and/or degranulate than do splenic NK cells upon stimulation through
activating receptors. We also found that smaller percentages of the circulating NK
(cNK) cells in the liver produce IFN-g and/or degranulate, compared to the liver
tissue resident NK (trNK) cells. In addition, IFN-g production by liver cNK cells is
not increased in IL-10 deficient mice, suggesting that their hyporesponsiveness is
not mediated by the presence of this anti-inflammatory cytokine in the hepatic
microenvironment. On the other hand, liver trNK cells express higher levels of the
inhibitory receptor NKG2A than do cNK cells, correlating with their increased
IFN-g production and degranulation.
Conclusions: Liver cNK cells’ hyporesponsiveness to stimulation through
activating receptors is independent of IL-10, but correlates with decreased
NKG2A expression compared to trNK cells. In addition, we demonstrate that liver
NK cells become further hyporesponsive upon continuous engagement of an
activating receptor on their cell surface.
Introduction
Natural killer (NK) cells play an important role in the innate
immune response to a number of pathogens and are among
the first cells to generate an immune response. They function
by destroying abnormal cells through the secretion of
cytotoxic granules, as well as secreting cytokines which shape
the subsequent immune response [1]. While most often
studied in the spleen, NK cells are found in other solid organs
including the thymus, uterus, and liver [2–6]. NK cells in
these solid organs can be differentiated from each other by
function, cell surface markers, and transcription factors
required for development [2].
Based on the mutually exclusive expression of two cell
surface markers, NK cells within the liver can be divided into
two populations. One population, tissue resident (tr) NK
cells, express CD49a but not CD49b (both are integrin
alpha subunits). The other population, conventional or
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circulating (c) NK cells, transit through the liver and express
CD49b but not CD49a [2]. The trNK cells also differ from
cNK cells in that they do not express several Ly49 receptors at
as high a level. In addition, the level of NKG2A expression is
higher on trNK cells as compared to cNK cells. However, it
appears that trNK cells as well as cNK cells produce similar
levels of IFN-g upon stimulation with phorbol 12-myristate
13-acetate (PMA) and ionomycin [2, 3, 7].
Previous studies have suggested that liver NK cells are
hyporesponsive compared to splenic NK cells based on their
dampened IFN-g response to IL-12/IL-18 stimulation [8, 9].
Their work demonstrated that within the liver there is a
population of NK cells that lack expression of Ly49H and
express higher levels of the inhibitory receptor NKG2A. It
also suggested that the increased expression of NKG2A
resulted in decreased function of the NK cells. While this
study did not differentiate between the circulating versus
trNK cells [2], the Ly49H, NKG2Aþ population of NK cells
described likely represents the trNK cells of the liver that
have been described more recently [2–4, 10].
In contrast to these prior studies, which assessed
activation of NK cells using cytokines, in the present study,
we sought to identify the factors involved in determining the
response of liver NK cells to engagement of their activating
receptors. We showed that smaller percentages of NK cells
isolated from the liver produce IFN-g and/or degranulate
when stimulated through activating receptors than do
splenic NK cells, and that this functional alteration within
the liver is limited to the cNK cells. In addition, IFN-g
production by liver cNK upon stimulation cells is not
increased in IL-10 deficient mice, suggesting that IL-10 does
not mediate NK cell hyporesponsiveness within the hepatic
microenvironment, as has been previously proposed. We
found that increased IFN-g production and degranulation
by trNK cells, compared to cNK cells, correlates with
increased expression of the inhibitory receptor NKG2A.
Finally, using an m157-transgenic mouse model system, we
demonstrated that continuous engagement of the Ly49H
activating receptor results in a further dampened IFN-g
response of Ly49Hþ liver NK cells to engagement of the
NK1.1 activation receptor.
Results
Smaller percentages of liver NK cells produce
IFN-g and/or degranulate compared to splenic
NK cells as a result of defects seen in
the circulating liver NK cell population
NK cells were harvested from the liver and spleen of wild-
type (WT) mice and assessed for the production of IFN-g
following stimulation with plate-bound antibodies to
individual activating receptors (NK1.1 or Ly49D). When
stimulated through NK1.1, a significantly lower percentage
of liver NK cells produced IFN-g, compared to splenic NK
cells (Fig. 1A and B). This was not due to a difference in the
expression of the activating receptor NK1.1 as the mean
fluorescence intensity (MFI) of NK1.1 expression on liver
NK cells was not significantly different from its expression
on splenic NK cells (data not shown). Similarly, when
stimulated through Ly49D, a significantly lower percentage
of liver NK cells produced IFN-g, compared to splenic NK
cells (Fig. 1A and B). This suggests that compared to splenic
NK cells, liver NK cells produce less IFN-g in response to
engagement of their activating receptors. Stimulation of liver
and splenic NK cells with PMA and ionomycin (Pþ I)
resulted in the production of similar levels of IFN-g,
suggesting that the defects are specific to stimulation
through cross-linking of the activating receptors.
As the hepatic NK cell population is composed of both
trNK cells (CD49aþ) and cNK cells (CD49a), we sought to
determine if both or only one of these populations are
hyporesponsive. To evaluate this, liver NK cells from WT
mice were stimulated through NK1.1 and assessed for IFN-g
production by the trNK cell and cNK cell populations. We
found when stimulated through NK1.1, a significantly
higher percentage of trNK cells produced IFN-g, compared
to cNK cells (Fig. 1C and D). Similar to previous studies,
when the liver NK cells were stimulated with Pþ I, both
populations were able to produce IFN-g (data not shown),
suggesting that the NK cells can still make IFN-g but
activation through the engagement of the activation receptor
was disrupted. Thus, only liver cNK cells appear to be
hyporesponsive to stimulation through activation receptors.
In addition to IFN-g production, we also compared
degranulation (assessed by expression of CD107a on the cell
surface) of NK cells from the liver and spleen in response to
plate bound stimulation through NK1.1. We found that a
significantly higher percentage of NK cells in the spleen
underwent degranulation in response to this stimulation
compared to liver NK cells (Fig. 2A and B). In addition, we
were able to show that a significantly higher percentage of
trNK cells underwent degranulation compared to cNK cells
within the liver (Fig. 2C). This was similar to the results seen
with IFN-g production by the respective NK cells.
Circulating NK cells from the livers of IL-10R2ko
mice, but not IL-10ko, mice produce more IFN-g
when stimulated through NK1.1, compared to
those from wild-type mice
We assessed the role that the anti-inflammatory cytokine
IL-10, found in the liver microenvironment, might play in
cNK cell function. Hepatic NK cells were harvested from
IL-10R2ko mice (in which the beta subunit of the IL-10
receptor is not expressed), stimulated through NK1.1, and
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assessed for IFN-g production. IFN-g was produced by a
significantly higher percentage of liver cNK as well as trNK
cells from IL-10R2ko mice compared to wild-type mice
(Fig. 3A). Splenic NK cells, however, were similar in both
groups of mice. This suggests that cytokines utilizing the
IL-10R2 subunit may be involved in the induction of
hyporesponsiveness in cNK cells in the liver but are not
involved in the spleen.
In addition to the IL-10 receptor, the IL-10R2 subunit is
shared by the receptors for multiple interleukins, including
IL-22, IL-26, IL-28, and IL-29 [11–13]. To look more
specifically at the role that IL-10 might be playing in the
induction of hyporesponsiveness, we assessed the produc-
tion of IFN-g by cNK from the liver of IL-10ko mice.
Surprisingly, we did not find a significant difference in the
production of IFN-g by hepatic cNK cells from IL-10komice
Figure 1. Liver NK cells produce less IFN-g than splenic NK cells as a result of defects seen in the circulating liver NK cell population. (A) Representative
histogram demonstrating IFN-g production by freshly isolated lymphocytes from the spleen and liver ofWTmice stimulatedwith PBS, plate bound PK136
(aNK1.1), plate bound 4E4 (aLy49D), or PMA and ionomycin (Pþ I). The plots were gated on NK cells (NK1.1þ, CD3). (B) The combined average
percentage of IFN-g producing NK cells from the spleen (black column, n¼ 6) and liver (white column, n¼ 6) of WT mice stimulated with plate
bound PK136, 4E4, or Pþ I. The results are presented as the mean SEM (p< 0.0001; ns, not signiﬁcant). (C) Representative histograms
demonstrating IFN-g production by freshly isolated liver lymphoctyes from aWTmouse stimulatedwith plate bound PK136 (aNK1.1). The histograms are
gated onNK cells (NK1.1þ, CD3), and the numbers represent the percentage of IFN-g producing CD49aþ or CD49aNK cells. The tinted histograms are
PBS-stimulated negative controls and the open dashed histograms represent PK136-stimulated NK cells. (D) The combined average percentage of IFN-g
producing CD49aþNK cells and CD49a- NK cells fromWTmice (n¼ 8) stimulatedwith plate bound PK136. The results are presented as themean SEM
(p< 0.0001; ns, not signiﬁcant).
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compared to those from WT mice (Fig. 3B). Furthermore,
we did not observe a difference in IFN-g production by
splenic NK cells from IL-10ko mice compared to those from
WT mice (Fig. 3B). This suggests that IL-10 does not play a
significant role in determining liver cNK cell function
following activation receptor engagement. Of note, we
observed decreased IFN-g production by trNK cells from
IL-10ko mice as compared to WT (Fig. 3B), suggesting that
IL-10 may alter liver trNK cell function. However, it should
be noted that systemically knocked-out IL-10 and IL-10R2
mice were use in these experiments, thus we cannot
distinguish if the effects observed above are NK cell intrinsic
or due to the loss of expression in another cell type.
Expression of higher levels of NKG2A corresponds
to increased IFN-g production and degranulation
upon stimulation through the engagement of
activating receptors
It has previously been demonstrated that inhibitory
receptors can ‘‘license’’ or ‘‘educate’’ NK cells [14–18].
The licensing status of a particular NK cell subset can be
Figure 2. Liver NK cells degranulate less than splenic NK cells as a result of defects seen in the circulating liver NK cell population. (A) Representative
histogram demonstrating CD107a expression by freshly isolated lymphocytes from the spleen and liver of WT mice stimulated with PBS or plate bound
PK136 (aNK1.1). The plots were gated on NK cells (NK1.1þ, CD3). (B) The combined average percentage of CD107aþ NK cells from the spleen (white
column, n¼ 10) and liver (black column, n¼ 10) of WTmice stimulated with plate bound PK136. To calculate%CD107aþ above background, the basal
percentage of cells with CD107a surface expression in the PBS stimulation was subtracted from the samples stimulated with aNK1.1. The results are
presented as the mean SEM (p< 0.0001). (C) The combined average percent CD107aþ above background in CD49aþ,CD49b NK cells versus
CD49a-,CD49bþ NK cells from WT mice (n¼ 10) stimulated with plate bound PK136. The results are presented as the mean SEM (p< 0.001).
Statistical analyses were performed using paired t-test.
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determined by assessing intracellular interferon-gamma
production following stimulation with plate-bound anti-
NK1.1 monoclonal antibody in the presence of brefeldin
A [19]. Our initial observations demonstrated that a higher
percentage of trNK cells produced IFN-g upon stimulation
throughNK 1.1 when compared to cNK cells within the liver.
We observed higher levels of NKG2A expression on trNK
cells compared to cNK cells (Supplemental Fig. S2),
consistent with observations by other groups [2, 20].
To address the role that NKG2A plays in educating NK
cells we assessed IFN-g production of NKG2Aþ and
NKG2A NK cells in both the spleen and liver following
stimulation through the NK1.1 receptor. We observed that
in both the spleen and the liver, NKG2AþNK cells produced
significantly more IFN-g compared to NKG2A NK cells
(Fig. 4A and B). Furthermore, when we subdivided the liver
NK cells in to trNK cells (CD49b, CD49aþ) and cNK cells
(CD49bþ, CD49a), we still observed that a significantly
higher percentage of NKG2Aþ NK cells produced IFN-g as
compared to NKG2A NK cells (Fig. 4C and D). As noted
earlier, trNK cells expressed lower levels of some Ly49
receptors, including the inhibitory receptor Ly49I. This
could partially explain the decreased IFN-g production by
the cNK cells as compared to the trNK cell population in the
liver. Taken together, this suggests, in contrast to previous
studies implying that increased NKG2A levels inhibit hepatic
NK cell function, that NKG2A engagement might play a role
in educating NK cells in both the spleen and the liver [9].
In addition, we observed increased IFN-g production by
trNK cells from WT mice as compared to IL10ko mice
(Fig. 3B). We also observed that trNK cells from WT mice
expressed higher levels of NKG2A than trNK cells from
IL10ko mice (Supplemental Fig. S1). Thus trNK cells from
WT mice produced more IFN-g and expressed higher levels
of NKG2A than trNK cells from IL10ko mice, further
suggesting that expression of NKG2A correlates with
increased function of the NK cells.
Similar to IFN-g production, degranulation was also
affected by expression of NKG2A onNK cells. In the liver, we
saw a significantly higher percentage of degranulation when
we compared NKG2Aþ to NKG2A NK cells in the total
hepatic NK cells population as well as when we broke the
hepatic NK cells into their trNK and cNK cell subsets
(Fig. 5A and B). The percent degranulation of NKG2Aþ NK
cells was not significantly different in the spleen compared to
NKG2A NK cells when we assessed the NK1.1þ, CD3
populations (Fig. 5A). However, when we gated on NK1.1þ,
CD49bþ, CD49b, CD3 cells in the spleen we noted
significantly increased degranulation in the NKG2Aþ NK
cells compared to the NKG2A NK cells (Fig. 5B).
Continuous engagement of an activating receptor
results in decreased IFN-gproduction by liver NK cells
Finally, we wanted to determine if continuous engagement
of one activating receptor (Ly49H) on NK cells in the liver
microenvironment would further decrease the ability of NK
cells to be activated via a separate activating receptor
(NK1.1). To accomplish this, liver NK cells were harvested
from both WT C57Bl6J mice and a transgenic (Tg)
Figure 3. Circulating NK cells from IL-10R2 komice but not IL-10 komice producemore IFN-g upon activation receptor stimulation than those fromWT
mice. (A) The percentage of circulating hepatic NK cells (NK1.1þ, CD3, CD49a), tissue resident hepatic NK cells (NK1.1þ, CD3, CD49aþ), and splenic
NK cells (NK1.1þ, CD3, CD49a) fromWT (n¼ 4) and IL-10R2 ko (n¼ 7) mice that are producing IFN-g following stimulation with plate bound PK136
(aNK1.1). (B) The percentage of circulating hepatic NK cells, tissue resident hepatic NK cells, and splenic NK cells fromWT (n¼ 8) and IL-10 ko (n¼ 8)mice
that produce IFN-g following stimulation with plate bound PK136 (aNK1.1). (p< 0.05; p< 0.01; p< 0.001).
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overexpressor (m157-Tg) of the Ly49H receptor’s ligand,
m157. These were stimulated in vitro with plate-bound
antibody to NK1.1 and assessed for IFN-g production. The
results are expressed as the ratio of the proportion of
Ly49Hþ NK cells producing IFN-g compared to the
proportion of Ly49H NK cells producing IFN-g. Because
not all NK cells express Ly49H and only the Ly49HþNK cells
are altered by the presence of m157, this ratio is expected to
be less than one if the continuous engagement of Ly49H
results in hyporesponsiveness of the Ly49Hþ NK cells. In
liver NK cells from m157-transgenic mice, this ratio was
significantly lower compared to those from non-transgenic
mice (Fig. 6A and B).Whenwe stimulated the cells with PþI,
we observed the ratio of both m157Tg and WT
mice to be one, suggesting that Hþ NK cells from m157-
Tg livers functioned normally upon stimulation with PþI.
(Fig. 6A and B). This is similar to previous work assessing
function of splenic NK cells from m157-Tg and WT
mice [21, 22]. This indicates that, similar to splenic NK
cells, upon continuous engagement of the Ly49H activating
receptor, liver NK cells become hyporesponsive to stimula-
tion through the NK1.1 activation receptor.
Figure 4. Increased NKG2A expression correlates with increased IFN-g production. (A) Representative histograms demonstrating IFN-g production by
freshly isolated lymphocytes from the spleen and liver of WTmice stimulated with plate bound PK136 (aNK1.1). The histograms were gated on NK cells
(NK1.1þ, CD3). The numbers represent the percentage of IFN-g producing NKG2Aþ or NKG2A NK cells. The tinted histograms are PBS-stimulated
negative controls and the open dashed histograms represent PK136-stimulated NK cells. (B) The combined average percentage of IFN-g producing
NKG2Aþ and NKG2A NK cells from the liver and spleen of WT mice (n¼ 7) stimulated with plate bound PK136. (C) Representative histograms
demonstrating IFN-g production by freshly isolated lymphocytes from the spleen and liver of WT mice stimulated with plate bound PK136. The
histogramswere gated on splenic NK cells (NK1.1þ, CD3, CD49bþ, CD49a), liver trNK cells (NK1.1þ, CD3, DX5, CD49aþ), or liver cNK cells (NK1.1þ,
CD3, CD49bþ, CD49a). The numbers represent the percentage of IFN-g producing NKG2Aþ or NKG2A NK cells. The tinted histograms are PBS-
stimulated negative controls and the open dashed histogram represent PK136-stimulated NK cells. (D) The combined average percentage of IFN-g
producing NKG2Aþ (black columns) and NKG2A NK cells (white columns) of the different spleen (n¼ 6) and liver populations (n¼ 9) of NK cells from
WT mice stimulated with plate bound PK136.The results are presented as the mean SEM (p< 0.01; p< 0.0001).
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Discussion
NK cells are an important lymphocyte subset of the innate
immune system. In addition to being found in the spleen
and circulating in the blood, NK cells can be found in a
number of solid organs. In fact, NK cells make up a large
proportion of the hepatic lymphocyte population [23–25].
Recent work suggests that NK cells in different organs
function differently and may derive from distinct
lineages [2–4, 10]. This appears to be the case in the liver,
where NK cells can be divided into two populations based
on the mutually exclusive expression of two cell surface
markers. These distinct populations represent tissue
resident NK cells and circulating NK cells.
In addition to cell surface markers, several studies have
demonstrated that tissue resident NK cells have different
transcription factor requirements than circulating NK cells
and likely arise from different progenitor cells [2, 26, 27].
Linear tracing studies demonstrated that PLZFhigh cells were
a precursor cells to NK1.1þ, CD49bNK cells residing in the
liver (trNK cells) but not classical circulating NK cells (cNK
cells) [27]. Another group identified a Lin, ID2þ, IL-7Raþ,
CD25, a4b7þ, Flt3 precursor that gave rise to all helper-
like innate lymphoid cells (ILCs, which include trNK cells)
but not to cNK cells [26]. Finally, it has been demonstrated
that cNK cells are Eomesþ, T-betþ while trNK cells are
Eomes, T-betþ [2]. Taken together, this suggests that trNK
cells (group 1 ILCs) are a distinct lineage from cNK cells seen
in the liver or spleen.
The liver microenvironment provides a unique situation
for the immune system in that it must be able to respond to
harmful pathogens while at the same time remain tolerant to
the many harmless antigens derived from commensal and
food sources from the gut [28, 29]. There are a number of
mechanisms believed to be involved in tolerance in the
hepatic immune system, including the induction of
regulatory T cells, regulatory Kupffer and dendritic cells,
and the presence of immunomodulatory cytokines [30, 31].
Several of these are likely involved in altering hepatic NK cell
function.
In this study, we demonstrate that hepatic NK cells
produced significantly less IFN-g and degranulate less than
NK cells from the spleen when stimulated through the
engagement of cell surface activating receptors. In
addition, NK cells from the hepatic microenvironment
become further hyporesponsive (dampened IFN-g pro-
duction upon stimulation of the NK1.1 activating
receptor) when the Ly49H activating receptor is continu-
ously engaged. This is similar to the activation-receptor
mediated hyporesponsiveness previously demonstrated in
splenic NK cells [21, 22].
Previous studies have shown dampened response of
hepatic NK cells to cytokine stimulation or treatment with
PMA and ionomycin [2, 32]. While one of these studies
found that cNK and trNK cells produced similar levels of
IFN-g in response to PMA and ionomycin [2], another
showed that cNK cells produced more IFN-g than trNK
cell [32] under similar conditions. Yet another study assessed
Figure 5. Increased NKG2A expression correlates with increased degranulation. (A) The combined average percentage of CD107aþ above background
in NKG2Aþ and NKG2A NK cells (NK1.1þ, CD3) from the liver and spleen of WT mice stimulated with plate bound PK136. (B) The combined average
percentage of CD107aþ above background in NKG2Aþ (black columns) and NKG2A NK cells (white columns) of splenic NK cells (NK1.1þ, CD3,
CD49bþ, CD49a), liver trNK cells (NK1.1þ, CD3, CD49b, CD49aþ) or liver cNK cells (NK1.1þ, CD3, CD49bþ, CD49a) from WT mice stimulated
with plate bound PK136.The results are presented as themean SEM (p< 0.05; p< 0.0001). Statistical analyseswere performed using paired t-test
on sample size of 10 mice in each group.
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cytokine production by Eomes (corresponding to trNK
cells) and Eomesþ (corresponding to cNK cells) NK cells
within the liver. Although the Eomes NK cells within the
liver produced a wide variety of cytokines, they appeared to
produce less IFN-g as compared Eomesþ NK cells upon
stimulation through activating receptors [33]. In contrast to
these studies, we demonstrate that hepatic cNK cells are
defective compared to trNK at producing IFN-g and
degranulation when stimulated through an activating
receptor (Figs. 4 and 5). This pattern is consistent with
prior work which demonstrated that in NK cells isolated
from human livers, CD49aþ NK cells produced more IFN-g
compared to CD49a NK cells upon stimulation with PMA
and ionomycin [34]. Taken together, this suggests that
hepatic trNK cells (ILCs) have an intrinsically different
response to activating receptor stimulation than do cNK cells
within the liver.
Our studies revealed that the hyporesponsiveness of the
total hepatic NK cell population is due to the presence of
hyporesponsive cNK (CD49a) cells and not trNK cells
(CD49aþ) NK cells. In fact, our data suggest that a higher
percentage of liver trNK cells produce more IFN-g and
degranulate more when compared to liver cNK cells. In
addition, a smaller percentage of cNK cells within the liver
produced IFN-g and/or degranulate compared to cNK cells
from the spleen suggesting that upon entering the liver from
the circulation, cNK cells become hyporesponsive.
There did not appear to be a difference in the relative
abundance of inhibitory Ly49 receptor family memebers
when comparing the cNK cells and splenic NK cells;
however, differences were noted between cNK and trNK cells
within the liver (Supplemental Fig. S2). Similar to previous
work, we found that NKG2A levels are comparable on the
splenic NK cells and liver cNK cells [2]. There is, however, a
higher percentage of NKG2A on the liver trNK cells
compared to the liver cNK cells and splenic NK cells.
Thus, altered NKG2A expression may explain in part the
functional differences between liver trNK and cNK cells, but
not the differences between hepatic and splenic cNK cells.
Studies assessing liver NK cells following adenoviral
infection suggest that the CD49a expression may be difficult
to use as a marker to differentiate cNK cells from trNK cells
due to the fact that CD49a is transiently upregulated during
activation of NK cells in vivo [20]. However in our
experiments, we assessed the function of NK cells in vitro
following plate bound stimulation of lymphocytes from the
spleen or liver. We then assessed IFN-g production or
degranulation (CD107a expression) on the different subsets
of NK cells based on cell surface markers. In our experi-
ments, we did not see a meaningful difference in cell surface
expression of CD49a on liver NK cells when comparing
NK1.1-stimulated to PBS controls (Supplemental Fig. S3).
NKG2A is a C-type lectin-like inhibitory receptor that
interacts with the non-classical MHC class I molecule Qa-1b
(human HLA-E) [35, 36]. The expression of this ligand is
dependent on peptides derived from classical MHC class I
molecules; thus its expression correlates with the overall
expression of MHC class I. Both IL-10 and TGF-b have been
shown to induce NKG2A expression [8, 9]. Other studies
suggest that IL-12 can induce NKG2A expression on
NKG2Cþ NK cells, possibly providing a negative feedback
mechanism [37]. It has been suggested that the NKG2A
Figure 6. Hepatic NK cells display activation receptor mediated hyporesponsiveness. (A) Representative dot plots demonstrating IFN-g production by
freshly isolated lymphocytes from the liver of WT and m157-Tg mice stimulated with PBS (control), plate bound PK136 (aNK1.1) or PMA and ionomycin
(Pþ I). The dot plots were gated on NK cells (NK1.1þ, CD3), and the numbers represent the percentage of IFN-g producing Ly49Hþ or Ly49H NK cells.
(B) The ratio of the percentage of IFN-g producing Ly49Hþ NK cells to the percentage of IFN-g producing Ly49H NK cells from WT mice (n¼ 8) and
m157-Tg mice (n¼ 10) stimulated with plate bound PK136 or Pþ I. The results are presented as the mean SEM (p< 0.05; ns, not signiﬁcant).
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population of NK cells might be maintained by the high level
of the immune suppressive cytokine IL-10 present in the
liver. Hyporesponsiveness of these NK cells was demon-
strated by a dampened IFN-g response to IL12/18 stimula-
tion [8, 9].
The increased function of the liver trNK cells in the setting
of elevated levels of the inhibitory receptor NKG2A on their
cell surface seems counterintuitive and is in contrast to
prior work suggesting that increased expression of NKG2A
on liver NK cells is responsible for their hyporesponsive-
ness [8, 9]. Our data, suggesting that liver trNK cells produce
more IFN-g, might be explained by the phenomena of
‘‘licensing’’ or ‘‘education’’ of the NK cells. This is a process
in which NK cells expressing inhibitory receptors for self-
MHC class I molecules become functionally competent to be
triggered through their activation receptors. Previous work
has demonstrated the expression of inhibitory receptors that
contain immunoreceptor tyrosine-based inhibitory motifs
(ITIMs) on the cell surface of the NK cell provides a
signal that allows for full functional competence of the NK
cell [14, 15]. The NKG2A receptor contains two ITIMs in its
cytoplasmic domain [35, 38]. Thus, the higher levels of
NKG2A on the liver trNK cells could better ‘‘educate’’ the
trNK cells and result in increased IFN-g production upon
stimulation through activation receptors.
Several other studies corroborate the idea that NKG2A
may in fact play a role in ‘‘educating’’ NK cells. It has been
shown that NK cells which lack KIRs and NKG2A expression
have decreased function and appear developmentally
immature [39]. Other work suggests that NKG2A expression
may be increased on human NK cells that lack self-
recognizing killer-cell immunoglobulin-like receptors
(KIRs), providing an inhibitory receptor that could be
used to educate the NK cells by interacting with self MHC
and acquire function [40, 41]. In addition, several studies
assessing degranulation of humanNK cells in response to the
K562 cell line demonstrated that CD94/NKG2A plays a
major role in normal NK cell education, both independent of
and in coordination with expression of KIRs [42, 43]. Thus
expression of the ‘‘inhibitory’’ receptor NKG2A can result in
increased function of the NK cell.
Another study demonstrated that NK cells freshly isolated
from surgical specimens from patients with hepatic
malignancies have less cytolytic activity compared to those
from autologous blood [44]. In this study, they observed a
higher proportion of CD16þ NK cells within the liver that
expressed a decreased number of inhibitory receptors [44].
This resulted in the liver containing a decreased number of
‘‘licensed’’ NK cells expressing inhibitory receptors com-
pared to blood and could explain their decreased cytolytic
function. Although there are clear differences between this
study and ours (NK cells from hepatocellular cancer patient
vs. healthy mouse), the fact that the function of a population
of NK cells in the liver may be controlled by inhibitory
receptor engagement is suggested by both.
IL-10 has been shown to have protective effects inmultiple
animal models of liver injury [45–47]. IL-10 has also been
shown to have immunosuppressive properties and inhibit
IFN-g and TNF production by NK cells in vitro [48]. Studies
have demonstrated that Kupffer cells (liver macrophages)
can secrete inhibitory factors, such as IL-10, as well [49]. It
has been suggested that IL-10 in the hepatic microenviron-
ment results in decreased function of liver NK cells in
response to IL-12/IL-18 [9]. Since cNK cells were defective in
the liver microenvironment, we tested the role that IL-10
may play in altering cNK cell function.
Similar to previous studies, we demonstrate that IL-10
levels can alter NKG2A expression on NK cells [8, 9]. We
demonstrate that loss of IL-10 results in lower NKG2A
expression on liver trNK, but not splenic or cNK, cells. This
correlates with decreased IFN-g production upon stimula-
tion through an activating receptor by trNK cells from
IL10komice as compared toWTmice. This also supports the
idea that NKG2A engagement serves as an ‘‘educating’’
receptor that increases IFN-g production rather than
inhibiting it.
Circulating NK cells from IL10R2 ko (knockout) mice
(which do not express the IL-10 receptor on their cells
surface due to deletion of one of the subunits) displayed
higher levels of IFN-g production as compared to WT mice
upon engagement of activating receptors. However, cNK
cells from IL-10 ko mice did not produce more IFN-g as
compared to WT mice upon engagement of activating
receptors. Of note, the IL10R2 receptor subunit makes up a
part of several receptors including those for IL-22, IL-26,
IL-28, and IL-29 [11–13]. Our study with IL-10ko versus
IL-10R2 ko mice suggests that IL-10 may not directly play a
role in maintaining the hyporesponsiveness of cNK cells that
are transiting through the liver; however, it is possible that
one or more of these other cytokines that uses the IL10R2
subunit may play a role in the induction of hyporesponsive-
ness of liver cNK cells. We did, however, see increased
function of trNK cells of the liver in IL10ko mice as
compared toWTmice. This suggests that IL-10may alter the
function of trNK cells, but not cNK cells.
Several key differences could explain the discrepancies
between our findings and those of prior studies. In our study,
we assess IFN-g production and degranulation following
stimulation with plate bound antibody to activating receptors
rather than cytokine stimulation. In addition,we differentiated
the NK cells into splenic, liver trNK and liver cNK, based on
CD49a or CD49b expression, when assessing function. Finally,
the mechanism in which the NK cells were isolated (perfusion
vs. mechanical disruption) from the liver likely plays a role
in the ratio of trNK to cNK cells obtained, which could alter
how the bulk NK cell population appears to function.
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It is now clear that NK cells have the ability to adapt
to their environment and show plasticity in their
response [5, 50]. The liver microenvironment is no
exception, as there appear to be a number of mechanisms
involved in altering the liver trNK and liver cNK cell
responses to activating receptor engagement. These mecha-
nisms are likely in place to prevent unwanted immune
responses to the number of harmless antigens that are
presented from the gut. These same protective mechanisms,
however, may be detrimental to the NK cell’s ability to
control pathogens in the liver including hepatotropic viruses
and tumors (both primary and metastatic). Further
understanding of how NK cell tolerance is maintained
within the hepatic microenvironment and development of
mechanisms to overcome this tolerance in specific circum-
stances may lead to novel therapeutic strategies, using NK
cells, to treat liver pathogens and tumors.
Materials and Methods
Mice
Them157-Tgmouse has been previously described [22]. The
IL-10R2 ko mice (B6.129S2-Il10rbtm1Agt/J) were obtained
from Paul Allen and Tony French (Washington University,
St. Louis, MO). The IL-10ko mice (B6.129P2-Il10tm1Cgn/J)
were purchased from the Jackson Laboratory. Mice were
maintained under specific pathogen-free conditions and
used after they reached 8 weeks of age. All animals received
humane care according to the criteria outlined in the ‘‘Guide
for the Care andUse of Laboratory Animals’’ prepared by the
National Academy of Sciences and published by the National
Institutes of Health (NIH publication 86-23 revised 1985).
The Animal Studies Committee at Washington University
approved all animal studies.
Antibodies
The following antibodies were obtained from EBioscience
(San Diego, CA, USA) or Biolegend (San Diego, CA, USA):
APC or PerCPcy5.5-PK136 (anti-NK1.1), APC-Cy7 or
PerCP-Cy5.5-145-2C11 (anti-CD3), Alexa488-XMG1.2
(anti-IFN-g), APC or PE-HMa1 (anti-CD49a), Pacific
Blue-DX5 (anti CD49b), PE-CD159a (anti-NKG2A_B6),
and streptavidin-PE. The FITC-16A11 (anti-NKG2A) was
obtained fromSantaCruz (Dallas, TX,USA). The 3D10 (anti-
Ly49H) and 6H121 (anti-m157) mAbs were purified from
hybridomas by the Protein Production and Purification Core
Facility of theRheumaticDiseasesCoreCenter atWashington
University and conjugated to biotin using EZ-Link Sulfo-
NHS-LC-LC-Biotin (Pierce, Rockford, IL, USA) according to
manufacturer’s protocol. Purified PK136 (anti-NK1.1) was
purchased from BioXcell (West Lebanon, NH, USA).
Isolation of hepatic lymphocytes
Livers were removed from mice and passed through a
100mm filter. The slurry was then passed through a 70mm
filter and transferred into a 15mL conical tube to be spun at
500g for 5min. The supernatant was decanted and the
pellet resuspended in 8mL of R2 (RPMI 1640, 2% FCS, 1%
Pen/Strep) or R10 (RPMI 1640, 10% FCS, Pen/Strep,
L-glutamine, b-mercaptoethanol) solution. The 8mL of liver
slurry was mixed with 5mL of room temperature Percoll
(SIGMA, Saint Louis, MO, USA). Following adequate
mixing, the solution was centrifuged at 835g for 20min
at room temperature. The supernatant was removed and the
remaining pellet was suspended in 10mL of RBC lysis buffer
for 5min. Lysis was terminated by the addition of 5mL of R2
or R10 solution, and the tube was centrifuged for 5min. This
pellet was washed with 10mL of R2 or R10 solution and
centrifuged again for 5min. The resulting pellet of hepatic
lymphocytes was resuspended in 1mL of R10 solution.
IFN-g assays
Splenic cells suspensions were generated as previously
described [21, 51] except they were also spun on Percoll
gradients and suspended in 10mL of RBC lysis buffer as
described for the isolation of hepatic lymphocytes. Either
PK136 mAb (anti-NK1.1) or 4E4 (anti-Ly49D) was diluted
to 2–4mg/mL in PBS and placed in 96-well or 24-well tissue
culture plates (Techno Plastic Product, Saint Louis, MO,
USA) and incubated at 378C for at least 90min. After
incubation, the plates were washed with PBS three times
prior to use for stimulation assays. For stimulation of NK
cells, splenocytes (1–2 107 cells/mL in R10) or hepatic
lymphocytes (approximately 1 107/mL in R10 for 96-well
plates and approximately 3 106/mL in R10 for 24-well
plates) were incubated in wells coated with anti-NK1.1 or
anti-Ly49D mAb for 1 h and then further incubated in the
presence of a 1000-fold dilution of stock brefeldin A
(GolgiPlug, BD Pharmingen, San Diego, CA, USA) for an
additional 6–8 h. We used 40mL of cells per well in the 96-
well plates and 333–500mL of cells per well in the 24-well
plates. Cells were harvested and stained for surface markers,
including NK1.1, CD3, CD49a, NKG2A, CD49b, and
Ly49H. Cells were then fixed and permeabilized using
Cytofix/Cytoperm solution (BD Pharmingen, San Diego,
USA), stained for IFN-g and analyzed on the FACSCalibur
or FACSCanto (BD Biosciences, San Jose, CA, USA).
CD107 assays
NK cells were isolated from the liver and spleen and run
through a Percoll gradient as described for the IFN-g assay.
Liver or splenic NK cells were centrifuged onto 24-well tissue
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culture plates that had been coated with 6mg of PK136 for
2 h at 378C. The NK cells were first stimulated for 1 h at
378C in the presence of 5mg/mL aCD107a-FITC (BD
Biosciences). Monensin (Biolegend) was added to achieve
2mM, and the incubation continued for 5 additional hours.
After the stimulation, cells were harvested and stained for
surface markers, including NK1.1, CD3, CD49a, NKG2A,
and CD49b. Cells were then analyzed by flow cytometry
(FCM) on the FACSCanto flow cytometer.
Statistical analysis
The data were analyzed with Microsoft Excel (Microsoft,
Redmond, WA, USA). Unpaired, two-tailed t-tests or paired
t-tests were used to determine statistically significant
differences between experimental groups. Error bars in the
figures represent the standard error of the mean (SEM).
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Figure S1. Tissue resident (tr) NK cells from WT mice
express higher levels of NKG2A than trNK cells from IL10ko
mice. The percentage of NK cells expressing NKG2A from
WT (black column, n¼8) or IL10ko mice (white column,
n¼4). NKG2A expression was assessed on splenic NK, liver
cNK (CD49aþ) and liver trNK (CD49aþ) cells.
Figure S2. Liver trNK cells, but not cNK cells, differ from
splenic NK cells in their expression of some inhibitory
receptors. Unstimulatedmurine hepatic and splenic NK cells
were stained for Ly49A, Ly49C, Ly49D, Ly49G2, Ly49H,
Ly49I and NKG2A and evaluated by flow cytometry.
Figure S3. Stimulation with plate bound PK136 does not
result in altered CD49a expression on liver NK cells.
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